These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 26795693)
41. On-treatment monitoring of chronic hepatitis B virus infection: an Asian-Pacific perspective. Chien RN J Gastroenterol Hepatol; 2010 May; 25(5):852-7. PubMed ID: 20546437 [TBL] [Abstract][Full Text] [Related]
42. Major causes of antiviral drug resistance and implications for treatment of hepatitis B virus monoinfection and coinfection with HIV. Locarnini S; Warner N Antivir Ther; 2007; 12 Suppl 3():H15-23. PubMed ID: 18284179 [TBL] [Abstract][Full Text] [Related]
43. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients? Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903 [TBL] [Abstract][Full Text] [Related]
44. Management of hepatitis B patients with antiviral resistance. Fung SK; Lok AS Antivir Ther; 2004 Dec; 9(6):1013-26. PubMed ID: 15651760 [TBL] [Abstract][Full Text] [Related]
45. [Modern strategy in the treatment of chronic hepatitis B: progress and prospects]. Isakov VA Eksp Klin Gastroenterol; 2007; (2):107-12. PubMed ID: 17539354 [No Abstract] [Full Text] [Related]
46. Molecular virology of hepatitis B virus and targets for antiviral intervention. Glebe D; König A Intervirology; 2014; 57(3-4):134-40. PubMed ID: 25034480 [TBL] [Abstract][Full Text] [Related]
47. Antiviral combination therapy for treatment of chronic hepatitis B, hepatitis C, and human immunodeficiency virus infection. Hofmann WP; Soriano V; Zeuzem S Handb Exp Pharmacol; 2009; (189):321-46. PubMed ID: 19048206 [TBL] [Abstract][Full Text] [Related]
48. Long-term results of treatment with nucleoside and nucleotide analogues (entecavir and tenofovir) for chronic hepatitis B. Asselah T; Marcellin P Clin Liver Dis; 2013 Aug; 17(3):445-50. PubMed ID: 23905815 [TBL] [Abstract][Full Text] [Related]
49. Tenofovir plus entecavir as rescue therapy for multidrug-resistant chronic hepatitis B. Scotto G; D'Addiego G; Giammario A; Campanale F; Fazio V Liver Int; 2012 Jan; 32(1):171-2. PubMed ID: 22098064 [No Abstract] [Full Text] [Related]
50. Hepatitis B virus replication and liver disease progression: the impact of antiviral therapy. Liaw YF Antivir Ther; 2006; 11(6):669-79. PubMed ID: 17310811 [TBL] [Abstract][Full Text] [Related]
52. [The efficacy of nucleoside/nucleotide analogue on chronic hepatitis B]. Lin Q; Zhang DZ Zhonghua Gan Zang Bing Za Zhi; 2009 Oct; 17(10):722-5. PubMed ID: 19874684 [No Abstract] [Full Text] [Related]
53. Treatment of chronic hepatitis B: current challenges and future directions. Chin R; Locarnini S Rev Med Virol; 2003; 13(4):255-72. PubMed ID: 12820187 [TBL] [Abstract][Full Text] [Related]
54. Viral hepatitis: towards the eradication of HCV and a cure for HBV. Asselah T; Marcellin P Liver Int; 2015 Jan; 35 Suppl 1():1-3. PubMed ID: 25529080 [No Abstract] [Full Text] [Related]
55. Antiviral therapy for chronic hepatitis B. Jafri SM; Lok AS Clin Liver Dis; 2010 Aug; 14(3):425-38. PubMed ID: 20638023 [TBL] [Abstract][Full Text] [Related]